Loncar Cancer Immunotherapy ETF (CNCR): Price and Financial Metrics ETF

Loncar Cancer Immunotherapy ETF (CNCR): $14.65

-0.27 (-1.81%)

POWR Rating

Component Grades



Buy & Hold




CNCR Stock Price Chart Interactive Chart >

Price chart for CNCR

CNCR Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market

Current price $14.65 52-week high $19.76
Prev. close $14.92 52-week low $12.76
Day low $14.65 Volume 100
Day high $14.87 Avg. volume 2,526
50-day MA $14.43 Dividend yield 0.00001%
200-day MA $15.16

Loncar Cancer Immunotherapy ETF (CNCR) ETF Bio

The investment objective of the Loncar Cancer Immunotherapy ETF seeks to replicate the Loncar Cancer Immunotherapy Index. The index was developed by a top biologist and includes large pharmaceutical and growth-oriented biotechnology firms that are focused on improving cancer treatments.


Issuer Exchange Traded Concepts
Expense Ratio 0.79%
Underlying Index Loncar Cancer Immunotherapy Index
Asset Class Equity
Sector Health & Biotech ETFs
Assets Under Management (AUM) 21.98M
Net Asset Value (NAV) $14.65
Options? Yes
Total Holdings 31

CNCR Price Returns

1-mo 6.70%
3-mo -0.68%
6-mo -12.85%
1-year -24.42%
3-year -24.55%
5-year -43.24%
YTD 6.70%
2022 -42.31%
2021 -19.24%
2020 36.53%
2019 24.22%
2018 -20.65%

CNCR Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNCR Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6489 seconds.